Pulmonary Syrup in pharma franchise in Mizoram

Pulmonary Syrup in PCD pharma franchise in Bhubaneswar

Pulmonary Syrup in top pharma company in Indore

Pulmonary Syrup in pcd pharma supplier in Gwalior

Pulmonary Syrup in phama franchise company in India
Pulmonary Syrup in phama distributor in Jodhpur

Home/Products /terbutaline-sulphate-i-point-p-point-1-point-25mg-syrup

Cufsniff BR Syrup

Composition : Terbutaline Sulphate I.P. 1.25mg + Bromhexine HCL I.P. 2mg + Guaiphenesin I.P. 50mg + Menthol I.P. 0.5mg

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 100 ml

Price : ₹88/-

Cufsniff BR Syrup is a comprehensive formulation designed to provide effective relief from cough and respiratory discomfort. This syrup combines four active ingredients: Terbutaline Sulphate, Bromhexine HCL, Guaifenesin, and Menthol, each contributing to a multi-faceted approach to managing respiratory symptoms.

Terbutaline Sulphate (1.25 mg) is a bronchodilator that helps to relax the muscles in the airways, making it easier to breathe. It is particularly beneficial for individuals experiencing bronchospasm associated with conditions such as asthma or chronic obstructive pulmonary disease (COPD).

Bromhexine HCL (2 mg) is a mucolytic agent that works by thinning and loosening mucus in the airways, facilitating easier expectoration. This helps to clear congestion and improve overall respiratory function.

Guaifenesin (50 mg) is an expectorant that further aids in the removal of mucus from the respiratory tract, enhancing the effectiveness of the other ingredients. It promotes productive cough, allowing for the clearance of phlegm and reducing the discomfort associated with chest congestion.

Menthol (0.5 mg) provides a soothing effect, offering a cooling sensation that can help relieve throat irritation and enhance the overall comfort of the respiratory system.

Read More

About the Product

Cufsniff BR Syrup is a comprehensive formulation designed to provide effective relief from cough and respiratory discomfort. This syrup combines four active ingredients: Terbutaline Sulphate, Bromhexine HCL, Guaifenesin, and Menthol, each contributing to a multi-faceted approach to managing respiratory symptoms.

Terbutaline Sulphate (1.25 mg) is a bronchodilator that helps to relax the muscles in the airways, making it easier to breathe. It is particularly beneficial for individuals experiencing bronchospasm associated with conditions such as asthma or chronic obstructive pulmonary disease (COPD).

Bromhexine HCL (2 mg) is a mucolytic agent that works by thinning and loosening mucus in the airways, facilitating easier expectoration. This helps to clear congestion and improve overall respiratory function.

Guaifenesin (50 mg) is an expectorant that further aids in the removal of mucus from the respiratory tract, enhancing the effectiveness of the other ingredients. It promotes productive cough, allowing for the clearance of phlegm and reducing the discomfort associated with chest congestion.

Menthol (0.5 mg) provides a soothing effect, offering a cooling sensation that can help relieve throat irritation and enhance the overall comfort of the respiratory system.

Common side effects may include nausea, dizziness, headache, and gastrointestinal discomfort. Some individuals may experience allergic reactions; monitoring for unusual symptoms is advised.

Cufsniff BR Syrup is indicated for the relief of cough and respiratory congestion associated with bronchial conditions.

Cufsniff BR Syrup should be used as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.

Store Cufsniff BR Syrup in a cool, dry place, away from direct sunlight. Ensure the cap is tightly closed after use and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation